2-(4-(2-Methoxyphenyl)piperazin-1-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carbaldehyde

Catalog No. :
ACIYOJ397
CAS No. :
433317-07-8
Molecular Formula :
C20H20N4O3
Molecular Weight :
364.40

IUPAC Name:2-(4-(2-methoxyphenyl)piperazin-1-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carbaldehyde

2-(4-(2-Methoxyphenyl)piperazin-1-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$263.00Login to see priceInquiryInquiry
5g97%$789.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-(2-Methoxyphenyl)piperazin-1-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carbaldehyde
IUPAC Name2-(4-(2-methoxyphenyl)piperazin-1-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carbaldehyde
Molecular FormulaC20H20N4O3
Molecular Weight364.40
SMILESO=CC1=C(N2CCN(C3=CC=CC=C3OC)CC2)N=C(C=CC=C4)N4C1=O
InChI KeyIHZYZBLXXGNDMS-UHFFFAOYSA-N
SynonymAKOS BBS-00001218;2-[4-(2-METHOXY-PHENYL)-PIPERAZIN-1-YL]-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE;4H-Pyrido[1,2-a]pyrimidine-3-carboxaldehyde, 2-[4-(2-methoxyphenyl)-1-piperazinyl]-4-oxo-
CAS No.433317-07-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACIYOJ397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGWQM827 route compound structure diagram
    ACGWQM82717481-62-8 In Stock
  4. Then
  5. ACIYOJ397 route product structure diagram
    ACIYOJ397433317-07-8
Inquiry

2. ACIYOJ397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIYOJ397 route product structure diagram
    ACIYOJ397433317-07-8
Inquiry

Comments (0)